Standard Bank Group Ltd
XBER:SKC2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Standard Bank Group Ltd
XBER:SKC2
|
ZA |
|
H
|
H & M Hennes & Mauritz AB
XBER:HMSB
|
SE |
|
Equifax Inc
NYSE:EFX
|
US |
|
G
|
Goldman Sachs Group Inc
BMV:GS
|
US |
|
D
|
Discover Financial Services
F:DC7
|
US |
|
V
|
Vimian Group AB
STO:VIMIAN
|
SE |
|
New York Times Co
NYSE:NYT
|
US |
|
S
|
Shin-Etsu Chemical Co Ltd
SWB:SEH
|
JP |
|
T
|
TAG Immobilien AG
SWB:TEG
|
DE |
|
M
|
Merck & Co Inc
VSE:MRK
|
US |
|
P
|
Pfizer Inc
LSE:0Q1N
|
US |
|
I
|
Intellia Therapeutics Inc
F:38I
|
US |
|
American Electric Power Company Inc
NASDAQ:AEP
|
US |
|
S
|
Sofina SA
SWB:8FS
|
BE |
|
Paychex Inc
NASDAQ:PAYX
|
US |
|
Biodesix Inc
NASDAQ:BDSX
|
US |
|
B
|
Burcon NutraScience Corp
DUS:BNE
|
CA |
|
Aristocrat Leisure Ltd
ASX:ALL
|
AU |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SKC2's stock price target?
Not Available
SKC2 does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Standard Bank Group Ltd?
Projected CAGR
-8%
Over the last 14 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 3 years is -8%.
What is the Net Income forecast for Standard Bank Group Ltd?
Projected CAGR
11%
Over the last 14 years, the compound annual growth rate for Net Income has been 10%. The projected CAGR for the next 3 years is 11%.